2021-01-11,"The Zacks Analyst Blog Highlights: Intellia Therapeutics, Editas Medicine, Fate Therapeutic, CRISPR Therapeutics and Vertex Pharmaceuticals"
2021-01-08,CRISPR Gene Editing Stocks Up After Intellia's Pipeline Update
2021-01-07,Genetics Stocks Pop After Intellia Offers Update For Gene-Editing Drugs
2021-01-07,Why Intellia Therapeutics Stock Is Soaring Today
2021-01-07,3 Biotech Technological Developments to Watch Out For in 2021
2021-01-07,Intellia Therapeutics Highlights Strategic Priorities and Anticipated Development Milestones for 2021
2021-01-06,A New Gene-Editing Technique May Be Able to Help Children Who Prematurely Age
2021-01-04,5 Disruptive Biotech Stocks With Solid Long-Term Potential
2021-01-01,"Intellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Could Be 41% Below Their Intrinsic Value Estimate"
2020-12-30,"The Zacks Analyst Blog Highlights: Moderna, Ultragenyx Pharma, Fate Therapeutics, Intellia Therapeutics, and Mersana Therapeutics"
2020-12-29,"Why CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics Stocks Are Sinking Today"
2020-12-29,5 Biotech Stocks That Have Gained More Than 200% in 2020
2020-12-21,"Genetics Stocks Ablaze: Editas, Crispr, Intellia Rocket; Uniqure Dives"
2020-12-16,Is NTLA A Good Stock To Buy Now?
2020-12-12,Intellia Therapeutics Achieves Normal Human Alpha-1 Antitrypsin Protein Levels in Non-Human Primates Through Targeted Gene Insertion for the Treatment of AAT Deficiency
2020-12-10,CRISPR Gene Editing: Owning the Future of Medicine
2020-12-09,Gene-Editing Stocks Skyrocket in $1.6 Billion Boom After Data
2020-12-07,Here Are The Winners Of This Year's Biggest Blood Cancer Meeting
2020-12-05,Intellia Therapeutics Presents New Preclinical Data Supporting Its CRISPR/Cas9-Engineered TCR-T Cell Treatment for Acute Myeloid Leukemia at the 62nd ASH Annual Meeting
2020-12-04,"Intellia Therapeutics Announces Closing of $201 Million Public Offering of Common Stock, Including Full Exercise of Underwriters Option  to Purchase Additional Shares"
2020-12-04,New Results on Blood Disorder Treatments Are Coming. Watch These Stocks.
2020-12-03,Intellia (NTLA) Catches Eye: Stock Jumps 7.8%
2020-12-01,Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
2020-11-30,Intellia Therapeutics Announces Proposed Public Offering of Common Stock
2020-11-11,Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments
2020-11-09,Intellia Therapeutics Doses First Patient in Landmark CRISPR/Cas9 Clinical Trial of NTLA-2001 for the Treatment of Transthyretin Amyloidosis
2020-11-09,"Analysts Have Lowered Expectations For Intellia Therapeutics, Inc. (NASDAQ:NTLA) After Its Latest Results"
2020-11-06,"Intellia Therapeutics, Inc. (NTLA) Q3 2020 Earnings Call Transcript"
2020-11-05,Intellia Therapeutics Announces Third Quarter 2020 Financial Results
2020-11-05,"Intellia Therapeutics, Inc. to Host Earnings Call"
2020-10-29,Intellia Therapeutics to Hold Conference Call to Discuss Third Quarter 2020 Earnings and Company Updates
2020-10-27,"Benzinga's Top Upgrades, Downgrades For October 27, 2020"
2020-10-19,Intellia Therapeutics Receives Authorization to Initiate Phase 1 Clinical Trial of NTLA-2001 for Transthyretin Amyloidosis (ATTR)
2020-10-07,Intellia Therapeutics Congratulates Co-Founder Jennifer Doudna On Winning the 2020 Nobel Prize in Chemistry for Inventing the Revolutionary CRISPR/Cas9 Genome Editing Technology
2020-10-07,Nobel Prize for Gene-Editing Innovators Boosts Crispr Therapeutics and Other Stocks
2020-10-05,Intellia Therapeutics Names John F. Crowley to Board of Directors
2020-09-29,Intellia Therapeutics Presents New Preclinical Data Showing Persistent In Vivo Editing and Durability of Effect Following CRISPR/Cas9-Based Treatment
2020-09-28,Intellia Therapeutics to Present at Chardans Virtual 4th Annual Genetic Medicines Conference
2020-09-22,Goldman Sachs: These 3 Stocks Are Poised to Surge by at Least 50%
2020-09-18,"Benzinga's Top Upgrades, Downgrades For September 18, 2020"
2020-09-02,Intellia Therapeutics to Present at Bairds 2020 Virtual Global Healthcare Conference
2020-08-11,We're Not Worried About Intellia Therapeutics' (NASDAQ:NTLA) Cash Burn
2020-08-11,"How Much Of Intellia Therapeutics, Inc. (NASDAQ:NTLA) Do Institutions Own?"
2020-08-06,"Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Intellia Therapeutics Announces Second Quarter 2020 Financial Results
2020-08-03,Intellia Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
2020-07-30,"Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q2 Earnings Expected to Decline"
2020-07-30,Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates
2020-07-25,Gene Therapy Companies Are Racing to Cure Sickle Cell. That Would Open the Door to Curing Dozens of Other Diseases.
2020-07-14,Is Intellia Therapeutics Stock a Buy?
2020-07-05,"Intellia Therapeutics, Inc. (NTLA): Hedge Funds Taking Some Chips Off The Table"
2020-07-02,Better Buy: Editas Medicine vs. Intellia
2020-06-10,Edited Transcript of NTLA earnings conference call or presentation 7-May-20 12:00pm GMT
2020-06-05,"Intellia Therapeutics Announces Closing of $115 Million Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares"
2020-06-05,Intellia Therapeutics (NTLA) Catches Eye: Stock Jumps 10.2%
2020-06-03,"Biotech Stock Roundup: GILD's Coronavirus Drug Update, NTLA-REGN Deal & More"
2020-06-03,Better Buy: CRISPR Therapeutics vs. Intellia
2020-06-03,Why Editas Medicine Is Now the CRISPR Stock to Really Watch
2020-06-02,Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
2020-06-02,Regeneron Expands Deal With Intellia for Hemophilia Treatments
2020-06-02,Stocks Still Rising to Begin June
2020-06-02,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs"
2020-06-02,"Regeneron, Intellia Expand Partnership To Develop Hemophilia Treatments"
2020-06-01,Intellia Therapeutics Announces Proposed Public Offering of Common Stock
2020-06-01,Here's Why Intellia Therapeutics Gained as Much as 18.0% Today
2020-06-01,Regeneron to expand development deal with Intellia Therapeutics
2020-06-01,Regeneron and Intellia Therapeutics Expand Collaboration to Develop CRISPR/Cas9-Based Treatments
2020-05-22,Here's Why Editas Could Beat Intellia to a CRISPR Therapy
2020-05-18,Intellia Therapeutics Sees Relative Strength Rating Rise To 92 Amid Cancer Treatment Development
2020-05-12,Intellia Therapeutics Reports Progress on CRISPR/Cas9 AML Cancer Therapy Using Proprietary Cell Engineering Process at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy
2020-05-11,"Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report"
2020-05-09,"Intellia Therapeutics, Inc. (NTLA) Q1 2020 Earnings Call Transcript"
2020-05-07,"Intellia Therapeutics Inc (NTLA) Reports Q1 Loss, Misses Revenue Estimates"
2020-05-07,Recap: Intellia Therapeutics Q1 Earnings
2020-05-07,Intellia Therapeutics Announces First Quarter 2020 Financial Results
2020-04-30,"Will Intellia Therapeutics, Inc. (NTLA) Report Negative Q1 Earnings? What You Should Know"
2020-04-30,"Intellia Therapeutics Names David Lebwohl, M.D., Chief Medical Officer"
2020-04-30,Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2020 Earnings and Company Updates
2020-04-28,Intellia Therapeutics to Present New Preclinical Data from Its CRISPR/Cas9 Programs at the 23rd Annual Meeting of the American Society of Gene and Cell Therapy
2020-04-13,"How Does Intellia Therapeutics, Inc. (NASDAQ:NTLA) Affect Your Portfolio Volatility?"
2020-04-06,"Alnylam, Dicerna Join Forces to Take on Arrowhead"
2020-03-31,FDA Accepts Investigational New Drug Application for CRISPR/Cas9-Based Sickle Cell Disease Therapeutic Candidate Developed Under Collaboration with Intellia Therapeutics
2020-03-24,Edited Transcript of NTLA earnings conference call or presentation 27-Feb-20 1:00pm GMT
2020-02-27,"Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates"
2020-02-27,Intellia Therapeutics Announces Fourth Quarter and Full-Year 2019 Financial Results
2020-02-20,Intellia (NTLA) to Report Q4 Earnings: What's in Store?
2020-02-20,Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2019 Earnings and Company Update
2020-02-19,"Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q4 Earnings Expected to Decline"
2020-02-12,Here's Why We're Not Too Worried About Intellia Therapeutics's (NASDAQ:NTLA) Cash Burn Situation
2020-02-10,Intellia Therapeutics Presents New Data From Its Engineered Cell Therapy and In Vivo Programs at Keystone Symposias Engineering the Genome Conference
2020-02-07,Implied Volatility Surging for Intellia (NTLA) Stock Options
2020-01-17,European ruling threatens Broad's CRISPR gene-editing patents
2020-01-09,Intellia Therapeutics Highlights Recent Progress and Anticipated 2020 Milestones
2020-01-06,Crispr puts first human in-body gene editing to test
2019-12-30,Gene-Editing Stocks Dive As Creator Of CRISPR Babies Sent To Prison
2019-12-30,Axsome Therapeutics jumps as migraine drug hits goals in late-stage trial
2019-12-25,Has Intellia Therapeutics (NTLA) Outpaced Other Medical Stocks This Year?
2019-12-17,"Atlas, MPM, Partners funnel $49M into a new gene-silencing startup"
2019-12-14,"Did Hedge Funds Drop The Ball On Intellia Therapeutics, Inc. (NTLA) ?"
2019-12-10,"Did Intellia Therapeutics, Inc. (NASDAQ:NTLA) Insiders Buy Up More Shares?"
